Digestive Remedies in Argentina

Abstract
Laboratorio Elea SACIF y A has applied an expansive marketing strategy to develop proton pump inhibitors sales with its flagship brand, Aziatop. This includes a high advertising budget and investments in new product developments in 2022. Furthermore, the company continues to strategise with an aggressive pricing strategy for its Aziatop brand and, subsequently, has gained important ground against generics and other mainstream brands, recovering value shares lost in proton pump inhibitors in 2020...

Euromonitor International's Digestive Remedies in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Digestive Remedies in Argentina

List Of Contents And Tables

DIGESTIVE REMEDIES IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Laboratorio Elea gains important ground driven by price and innovation
Antacids lose space to proton pump inhibitors, as omeprazole becomes a key ingredient
Unhealthy diets and ageing population support sales in digestive remedies in 2022
PROSPECTS AND OPPORTUNITIES
Demand set to rise, as growing working age population drives increase in digestive problems
Omeprazole within proton pump inhibitors is forecast to keep growing taking volume from antacids
Naturally-positioned digestive remedies are set to rise over the forecast period
CATEGORY DATA
Table 1 Sales of Digestive Remedies by Category: Value 2017-2022
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN ARGENTINA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources